GPR55
GPR55 is a lysophosphatidylinositols and cannabinoids receptor. It is involved in various signaling cascade and plays a role in neuropathic/inflammatory pain, cancer and metabolic regulation etc.
Products for GPR55
- Cat.No. Product Name Information
-
GC12728
Abn-CBD
AbnCBD, ortho-Cannabidiol, o-CBD
GPR55 cannabinoid receptor agonist -
GC35339
Anandamide
AEA, Anandamide
An immune modulator in the central nervous system -
GC35694
CID 16020046
CID 16020046 is a potent and selective GPR55 antagonist and inhibits GPR55 constitutive activity with an IC50 of 0.15 μM. CID 16020046 inhibits GPR55-mediated Ca2+ signaling and GPR55-mediated ERK1/2 phosphorylation. CID 16020046 reduces wound healing in endothelial cells and is involved in the regulation of platelet function.
-
GC73616
GPR55 agonist 4
GPR55 agonist 4 (Compound 28) is a GPR55 agonist (EC50: 131 nM, and 1.41 nM for hGPR55 and rGPR55).
-
GC44217
ML-184
CID-2440433
GPR55 is a G protein-coupled receptor that is weakly activated by some cannabinoids (CBs) at nM concentrations but displays a 5- to 10-fold greater stimulation in response to 1 μM lysophosphatidylinositol (LPI). -
GC14026
ML-193
CID-1261822
GPR55 antagonist -
GC13513
O-1602
Abn-CBDO, Abnormal Cannabidiorcin, Abnormal Cannabidiorcinol, Abnormal Cannabiorcodiol
GPR55 cannabinoid receptor agonist
-
GC16103
Oleylethanolamide
Oleic Acid Ethanolamide, OEA
Oleylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis. -
GC17777
Palmitoylethanolamide
Palmidrol, PEA
GPR55 agonist -
GC69771
PSB-SB-487
PSB-SB-487 is an effective GPR55 antagonist and CB2 agonist, with an IC50 of 0.113 µM for GPR55 and a Ki of 0.292 µM for human CB2. PSB-SB-487 can be used to study diabetes, Parkinson's disease, neuropathic pain, and cancer.